Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions

[1]  Malcolm Rowland,et al.  Clearance concepts in pharmacokinetics , 1973, Journal of Pharmacokinetics and Biopharmaceutics.

[2]  T. Walle,et al.  Identification of major sulfate conjugates in the metabolism of propranolol in dog and man. , 1983, Drug metabolism and disposition: the biological fate of chemicals.

[3]  T. Walle,et al.  Stereoselective binding of the (-)-enantiomer of propranolol to plasma and extravascular binding sites in the dog. , 1983, Drug Metabolism And Disposition.

[4]  N. Holford,et al.  Dose-dependent elimination of propranolol and its major metabolites in humans. , 1983, Journal of pharmaceutical sciences.

[5]  T. Walle,et al.  Quantitative metabolic fate of propranolol in the dog, rat, and hamster using radiotracer, high performance liquid chromatography, and gas chromatography-mass spectrometry techniques. , 1983, Drug metabolism and disposition: the biological fate of chemicals.

[6]  N. Holford,et al.  Stereoselective disposition and glucuronidation of propranolol in humans. , 1982, Journal of pharmaceutical sciences.

[7]  D. Effeney,et al.  A technique to study hepatic and intestinal drug metabolism separately in the dog. , 1982, The Journal of pharmacology and experimental therapeutics.

[8]  D. Effeney,et al.  Lack of gastrointestinal metabolism of propranolol in dogs after portacaval transposition. , 1982, The Journal of pharmacology and experimental therapeutics.

[9]  S. Riegelman,et al.  Stereospecific assay for (-)- and (+)-propranolol in human and dog plasma. , 1980, The Journal of pharmacology and experimental therapeutics.

[10]  F. Abramson,et al.  The pathways of propranolol metabolism in dog and rat liver 10,000g supernatant fractions. , 1980, Drug metabolism and disposition: the biological fate of chemicals.

[11]  S. Riegelman,et al.  Determination of propranolol and its major metabolites in plasma and urine by high-performance liquid chromatography without solvent extraction. , 1980, Journal of chromatography.

[12]  P. Routledge,et al.  Clinical Pharmacokinetics of Propranolol , 1979, Clinical pharmacokinetics.

[13]  T. Walle,et al.  Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique. , 1979, Research communications in chemical pathology and pharmacology.

[14]  R. Vestal,et al.  Direct measurement of propranolol bioavailability during accumulation to steady-state. , 1978, British journal of clinical pharmacology.

[15]  W. Jusko,et al.  Analysis and disposition of low dose oral propranolol. , 1978, Research communications in chemical pathology and pharmacology.

[16]  T. Suzuki,et al.  Drug absorption and metabolism studies by use of portal vein infusion in the rat. II. Influence of dose and infusion rate on the bioavailability of propranolol. , 1974, Chemical & pharmaceutical bulletin.

[17]  Shand Dg,et al.  The disposition of propranolol. I. Elimination during oral absorption in man. , 1972 .

[18]  D. Shand,et al.  The Disposition of Propranolol , 1972 .

[19]  D. Shand,et al.  The disposition of propranolol. I. Elimination during oral absorption in man. , 1972, Pharmacology.